Society guideline links: Pneumococcal vaccination

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Immunizations in adults" and "Society guideline links: Immunizations in children and adolescents" and "Society guideline links: Cochlear implant infections".)

International

●World Health Organization (WHO): Guideline on considerations for pneumococcal vaccination in older adults (2021)

●WHO: Pneumococcal vaccines – Position paper on their use in community outbreak settings (2021)

•WHO: Position paper on pneumococcal conjugate vaccines in infants and children under 5 years of age (2019)

Canada

●Public Health Agency of Canada (PHAC): Canadian Immunization Guide – Pneumococcal vaccines (2024)

●National Advisory Committee on Immunization (NACI): An Advisory Committee Statement (ACS) on recommendations for public health programs on the use of pneumococcal vaccines in children, including the use of 15-valent and 20-valent conjugate vaccines (2024)

●NACI: An Advisory Committee Statement (ACS) on interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations (2023)

●NACI: An Advisory Committee Statement (ACS) on public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines (2023)

United States

●Advisory Committee on Immunization Practices (ACIP): Pneumococcal vaccine recommendations

●Centers for Disease Control and Prevention (CDC): Pneumococcal disease – For health care providers

•Clinical features of pneumococcal disease

•Clinical guidance for pneumococcal disease

•Clinical overview of pneumococcal disease

•Pneumococcal vaccine recommendations

●American Academy of Pediatrics (AAP): Red Book – Streptococcus pneumoniae (pneumococcal) infections (2024)

●CDC: Epidemiology and Prevention of Vaccine-Preventable Diseases ("The Pink Book") – Pneumococcal disease (2021)

Europe

●European Centre for Disease Prevention and Control: Vaccine scheduler – Immunisation schedules by target disease: Pneumococcal disease

United Kingdom

●UK Health Security Agency (UKHSA): The Green Book – Immunisation against infectious disease: Pneumococcal (2013, updated 2023)

India

●Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Pneumococcal conjugate vaccines (PCVs)

●IAP ACVIP: Pneumococcal polysaccharide vaccine (PPSV23)

●Indian Chest Society (ICS) and National College of Chest Physicians (NCCP) of India: Clinical practice guidelines – Indian consensus-based recommendations on pneumococcal vaccination for adults, 2019 (published 2020)

Australia–New Zealand

●Australian Technical Advisory Group on Immunisation (ATAGI): The Australian Immunisation Handbook – Pneumococcal disease (2024)